Retinoblastoma (RB1) pocket domain mutations and promoter hyper-methylation in head and neck cancer

Cellular Oncology

Volumn 37, Issue 3, 2014, Pages 203-213

  Sabir, Maimoona ^a   Baig, Ruqia Mehmood ^a,c   Ali, Kashif ^a,b   Mahjabeen, Ishrat ^a   Saeed, Muhammad ^a   Kayani, Mahmood Akhtar ^a  

^a Cancer Genetics Lab Department of Biosciences COMSATS Institute of Information Technology ^*  (Pakistan)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c PMAS ARID AGRICULTURE UNIVERSITY   (Pakistan)

Author keywords

Carcinogenesis; HNC; Mutation analysis; Promoter methylation analysis; RB1

Indexed keywords

RETINOBLASTOMA PROTEIN; RETINOBLASTOMA PROTEIN 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CONTROLLED STUDY; DNA METHYLATION; EXON; FEMALE; FRAMESHIFT MUTATION; GENE MUTATION; GERMLINE MUTATION; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RETINOBLASTOMA; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; ADOLESCENT; CHEMISTRY; COHORT ANALYSIS; DNA SEQUENCE; GENETICS; HEAD AND NECK TUMOR; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PAKISTAN; PROCEDURES; PROTEIN TERTIARY STRUCTURE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BASE SEQUENCE; CASE-CONTROL STUDIES; COHORT STUDIES; DNA METHYLATION; FEMALE; GERM-LINE MUTATION; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MUTATION, MISSENSE; PAKISTAN; PROMOTER REGIONS, GENETIC; PROTEIN STRUCTURE, TERTIARY; RETINOBLASTOMA PROTEIN; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 84904717041     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-014-0173-9     Document Type: Article

References (49)

1. J.H. Dannenberg, L. Schuijff, M. Dekker, M.V. Valk, H. Riele, Tissue-specific tumor suppressor activity of retinoblastoma gene homologs p107 and p130. Genes & Dev 18, 2952-2962 (2004)
2. S.M. Rubin, A.L. Gall, N. Zheng, N.P. Pavletich, Structure of the Rb C-Terminal Domain Bound to E2F1-DP1: A Mechanism for Phosphorylation-Induced E2F. Release Cell 123(6), 1093-1106 (2005)
3. E.J. Morris, N.J. Dyson, Retinoblastoma protein partners. Adv Can Res 82, 1-54 (2001)
4. E. Berge, S. Knappskog, S. Geisler, V. Staalesen, M. Pacal, A. Borresen-Dale, P. Puntervoll, J. Lillehaug, P. Lønning, Identification and characterization of retinoblastoma gene mutations disturbing apoptosis in human breast cancers. Mol Cancer 9, 173-186 (2010)
5. V. Dalamon, E. Surace, F. Giliberto, V. Ferreiro, C. Fernandez, I. Szijan, Detection of germline mutations in Argentine retinoblastoma patients: low and full penetrance retinoblastoma caused by the same germline truncating mutation. J Biochem Mol Biol 37(2), 246-253 (2004)
6. P.P. Claudio, C.M. Howard, C. Pacilio, C. Cinti, G. Romano, C. Minimo, N.M. Maraldi, J.D. Minna, L. Gelbert, L. Leoncini, G.M. Tosi, P. Hicheli, M. Caputi, G.G. Giordano, A. Giordano, Mutations in the retinoblastoma-related geneRB2/p130 in lung tumors and suppression of tumor growth in vivo by retrovirus-mediated gene transfer. Cancer Res 60, 372-382 (2000)
7. H. Miyamoto, T. Shuin, S. Torigoe, Y. Iwasaki, Y. Kubota, Retinoblastoma gene mutations in primary human bladder cancer. British J Cancer 71, 831-835 (1995)
8. Y. Kubota, K. Fujinami, H. Uemura, Y. Dobashi, H. Miyamoto, Y. Iwasaki, H. Kitamura, T. Shuin, Retinoblastoma gene mutations in primary human prostate cancer. Prostate 27, 314-320 (1995)
9. N.M. Christopher, L.C. Scott, R.F. Sejal, Rb loss abrogates cell cycle control and genome integrity to promote liver tumorigenesis. Gastroenterology 133, 976-984 (2007)
10. D.J. Venter, K.L. Bevan, R.L. Ludwig, Retinoblastoma gene deletions in glioblastomas. Oncogene 6, 445-448 (1991)
11. W.G. Cance, M.F. Brennan, M.E. Dudas, Altered expression of the retinoblastoma gene product in human sarcomas. N Engl J Med 323, 1457-1462 (1990)
12. S.M. Komblau, N. Chen, A.D. Giglio, Retinoblastoma protein expression is frequently altered in chronic lymphocytic leukemia. Cancer Res 54, 242-246 (1994)
13. S. Koontongkaew, L. Chareonkitkajorn, L.A. Chanvitan, Alterations of p53, pRb, cyclinD(1) and cdk4 in human oral and pharyngeal squamous cell carcinomas. Oral Oncol 36, 334-339 (2000)
14. T. Krecicki, R. Smigiel, M. Fraczek, M. Kowalczyk, M.M. Sasiadek, Studies of the cell cycle regulatory proteins P16, cyclin D1 and retinoblastoma protein in laryngeal carcinoma tissue. J Lary& Otology 118, 676-680 (2004)
15. L.L. Gleich, F.N. Salamone, Molecular genetics of head and neck cancer. Cancer Control 9(5), 369-378 (2002)
16. V. Canzonieri, L. Barzan, G. Franchin, E. Vaccher, R. Talamini, S. Sulfaro, G baldassarre, alteration of G1/S transition regulators influences recurrences in head and neck squamous carcinomas. J Cell Physiol 227, 233-238 (2012)
17. Y. Nakahara, S. Shintani, M. Mihara, Alterations of Rb, p16 (INK4A) and cyclin D1 in the tumorigenesis of oral squamous cell carcinomas. Cancer Lett 160, 3-8 (2000)
18. G.M. Sabbir, A. Roy, S. Mandal, Deletion mapping of chromosome 13q in head and neck squamous cell carcinoma in Indian patients: correlation with prognosis of the tumour. Int J Exp Path 87, 151-161 (2006)
19. V.K. Gupta, A.P. Schmidt, M.E. Pashia, J.B. Sunwoo, S.B. Scholnick, Multiple regions of deletion on chromosome arm 13q in head-and-neck squamous-cell carcinoma. Int J Cancer 22, 453-457 (1999)
20. M.J. Worsham, K.M. Chen, J.K. Stephen, S. Havard, M.S. Benninger, Novel approaches to global mining of aberrantly methylated promoter sites in squamous head and neck cancer. Otolaryngology Head Neck Surg 143(1), 116-121 (2010)
21. E. Taioli, C. Ragin, X. Wang, J. Chen, S.M. Langevin, A.R. Brown, S.M. Gollin, S. Garte, R.W. Sobol, Recurrence in oral and pharyngeal cancer is associated with quantitative MGMT promoter methylation. BMC Cancer 9, 354 (2009)
22. P.M. Das, R. Singal, DNA methylation and cancer. J Clin Oncol Biol Neoplasia 22, 4632-4662 (2004)
23. M. Nakamura, T. Watanabe, U. Klangby, C. Asker, K. Wiman, Y. Yonekawa, P. Kleihues, H. Ohgaki, P14arf deletion and methylation in genetic pathways to glioblastomas. Brain Pathol 11, 159-168 (2001)
24. S. Demokan, A. Chuang, Y. Suoglu, M. Ulusan, Z. Yalniz, J.A. Califano, N. Dalay, Promoter methylation and loss of p16ink4a gene expression in head and neck cancer. Head & Neck 34(10), 1470-1475 (2012)
25. P. Gonzalez-Gomez, M.J. Bello, M.E. Alonso, D. Arjona, J. Lomas, J.M. de Campos, J.M. de Campos, A. Isla, J.A. Rey, CpG island methylaion status and mutation analysis of the RB1 gene essential promoter region and protein-binding pocket domain in nervous system tumors. Br J Cancer 13(1), 109-114 (2003)
26. D.J. Simpson, N.A. Hibberts, A.M. McNicol, R.N. Clayton, W.E. Farrell, Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpGisland. Cancer Res 60, 1211-1216 (2000)
27. R.M. Baig, I. Mahjabeen, M. Sabir, N. Masood, K. Ali, F.A. Malik, M.A. Kayani, Mutational spectrum of gelsolin and its down regulation is associated with breast cancer. Disease Mark 34, 71-80 (2013)
28. I. Mahjabeen, R.M. Baig, N. Masood, M. Sabir, F.A. Malik, M.A. Kayani, Sequence variations of OGG1 gene in head and neck cancer patients. Asian Pac J Cancer Prev 12, 2779-2783 (2001)
29. U. Inayat, M.A. Kayani, R. Faryal, Sporadic mutations and expression analysis of spleen tyrosine kinase gene in breast cancer: a preliminary report. Pol J Pathol 63(2), 106-111 (2012)
30. C.S. Chim, C. Tam, R. Liang, Y.L. Kwong, P15 and P16 gene methylation in adult acute leukemia: lack of prognostic significance. Cancer 91, 2222-2229 (2001)
31. J. Alonso, P. García-Miguel, J. Abelairas, M. Mendiola, E. Sarret, M.T. Vendrell, A. Navajas, A. Pestaña, Spectrum of germlineRB1 gene mutations in Spanish retinoblastoma patients: phenotypic and molecular epidemiological implications. Hum Mutat 17(5), 412-422 (2001)
32. P.C. Ng, S. Henikoff, SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res 31(13), 3812-3814 (2003)
33. INK4a/Cyclin D1/RB pathway in gastrointestinal tract endocrine tumors. Am J Clinic Pathol 130, 535-542 (2008)
34. B. Joseph, G. Mamatha, G. Raman, M.P. Shanmugam, G. Kumaramanickavel, Methylation status of RB1promotor in Indian retinoblastoma patients. Cancer Biol Ther 3(2), 184-187 (2004)
35. N. Masood, M.A. Kayani, Mutational analysis of xenobiotic metabolizing genes (CYP1A1 and GSTP) in sporadic head and neck cancer patients. Genetics and Mol Biol 34(4), 533-538 (2011)
36. C.D. Llewellyn, L.W. Jhonson, K.A. Warnakulasuriya, nd younger: a case-control study in Southern England. J Oral Pathol Med 33(9), 525-532 (2004)
37. C.H. Shiboski, S.C. Shiboski, S Silverman S (2000). Trends in oral cancer rates in the United States, 1973-1996. Community Dent Oral Epidemiol 28, 249-256 (2000)
38. A. Czech, I. Fedyunin, G. Zhang, Z. Ignatova, Silent mutations in sight: co-variations in tRNA abundance as a key to unravel consequences of silentmutations. Molecular Biosystems 6(10), 1767-1772 (2010)
39. O.V. Babenko, S.V. Saakyan, A.F. Brovkina, V.M. Kozlova, V.V. Strelnikov, D.V. Zaletaev, M.V. Nemtsova, Spectrum and frequencies of RB1 structural defects in retinoblastoma. Mol Biol 36, 487-492 (2002)
40. V. Blanquet, C. Turleau, M.S. Gross-Morand, C. Senamaud-Beaufort, F. Doz, C. Besmond, Spectrum of germline mutations in the RB1 gene: a study of 232 patients with hereditary and non-hereditary retinoblastoma. Hum Mol Genet 4, 383-388 (1995)
41. K.W. Choy, C.P. Pang, C.B. Yu, H.L. Wong, J.S. Ng, D.S. Fan, K.W. Lo, J.T. Chai, J. Wang, W. Fu, D.S. Lam, Loss of heterogensity and mutations are the major mechanism of Rb1 gene inactivation in Chinese patients with sporadic retinoblastoma. Hum Mutat 20, 408-417 (2002)
42. M. Ata-ur-Rasheed, G.K. Vemuganti, S.G. Honavar, N. Ahmed, S.E. Hasnain, C. Kannabiran, Mutational analysis of the RB1 gene in Indian patients with retinoblastoma. Ophthal Genet 23, 121-128 (2002)
43. P. Kadam-Pai, X.Y. Su, J.J. Miranda, A. Soemantri, N. Saha, C.K. Heng, P.S. Lai, Ethnic variations ofa retinoblastoma susceptibility gene (RB1) polymorphism in eight Asian populations. J Genet 82(1-2), 33-37 (2003)
44. R.H. Barbosa, F.C. Aguiar, M.F. Silva, R.A. Costa, F.R. Vargas, E. Lucena, L.M. de Almeida, M. de Carvalho Souza, C. Bittar, P. Ashton Prolla, C.R. Bonvicino, H.N. Seuánez, Screening of RB1 alterations in Brazilian patients with retinoblastoma and relatives with retinoma: phenotypic and genotypic associations. Invest Ophthalmol Vis Sci 7 54(5), 3184-3194 (2013)
45. C.A. Righini, F. De Fraipont, J.F. Timsit, Tumor specific methylation in saliva: a promising biomarker for early detection of head and neck recurrence. Clinic Cancer Res 13, 1179-1185 (2007)
46. P.K. Ha, J.A. Califano, Promoter methylation and inactivation of tumour-suppressor genes in oral squamous-cell carcinoma. Lancet Oncol 7(1), 77-82 (2006)
47. D.J. Smiraglia, L.H. Smith, J.C. Lang, Differential targets of CpG island hypermethylation in primary and metastatic head and neck squamous cell carcinoma (HNSCC). J Med Gene 40, 25-33 (2003)
48. F.D. Hong, H.J. Huang, H. To, L.J. Young, A. Oro, R. Bookstein, E.Y. Lee, W.H. Lee, Structure of the human retinoblastoma gene. Proc Natl Acad Sci U S A 86(14), 5502-5506 (1989)
49. D. Yin, D. Xie, W.K. Hofmann, C.W. Miller, K.L. Black, H.P. Koeffler, Methylation, expression and mutation analysis of the cell cycle control genes in human brain tumors. Oncogene 21(54), 8372-8378 (2002)